INCY

Incyte
INCY

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$13.11B
EV
$10.75B
Shares Outstanding
193.57M
Beta
0.68

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$73.88
P/E 2025E
11.63x
P/Revenue 2025E
2.79x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Incyte Corporation

gainify
INCY

Incyte Corporation

INCY

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxoliti...

Sector

Healthcare

Industry

Biotechnology

CEO

Hoppenot, Herve

Employees

2,617

IPO Date

1993-11-04

Headquarters

1801 Augustine Cut-Off, Wilmington, Delaware, 19803, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.